BCL2 and melanoma: CM derived from bcl-2 overexpressing melanoma cells treated with IL-1β blocking antibody caused a strong inhibition of M2 macrophage polarization, resulting in significant reduction of M2 (CD206, CCL1, CCL22) and induction of M1 (COX-2 and IL-12) markers (figure 3D).